Characterization of dilated cardiomyopathy using tissue phase mapping and extracellular volume measurement

Background Non-ischemic dilated cardiomyopathy (DCM) is a relatively common cause of left ventricular dysfunction. Microscopic scar may be a cause of regional and global left ventricular dysfunction in DCM patients. The aim of this study was to evaluate changes in regional myocardial structure, function, and dyssynchrony using a novel noninvasive MR imaging protocol. Methods Eleven patients with suspected non-ischemic cardiomyopathy underwent cardiac MRI (CMR) on a 1.5T magnet (Magnetom Avanto or Aera, Siemens Healthcare, Erlangen, Germany). In addition to the conventional CMR viability protocol, patients underwent both tissue phase mapping (TPM) and T1 mapping with a modified look-locker inversion recovery (MOLLI) technique pre and between 10 and 25 minutes post 0.2 mmol/kg adminstration of an extracellular gadolinium agent. These sequences were performed through the left ventricle in the short axis orientation at basal, mid-chamber, and apical levels. The hematocrit was collected within 48 hours of the CMR to calculate segmental ECV values as described by Kellman, et al., as a marker of microscopic fibrosis. TPM analysis was used to determine the degree of segmental wall motion abnormality. Radial, longitudinal and absolute velocities